Actuate Therapeutics, Inc. (ACTU) Income Statement
8 Followers
Actuate Therapeutics, Inc. Income Statement
Last quarter (Q0 0), Actuate Therapeutics, Inc.'s total revenue was $―, a decrease of ― from previous quarter. In Q0, Actuate Therapeutics, Inc.'s net income was $-5.97M. See Actuate Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ ―
Cost of Revenue
$ ―
Gross Profit
$ ―
Operating Expense
$ 24.97M
Operating Income
$ -24.97M
Net Non Operating Interest Income Expense
$ 309.03K
Other Income Expense
$ 79.82K
Pretax Income
$ -24.74M
Tax Provision
$ ―
Earnings From Equity Interest Net Of Tax
$ ―
Net Income Common Stockholders
$ -24.74M
Basic EPS
$ -17.24
Diluted EPS
$ -17.24
Basic Average Shares
$ 1.43M
Diluted Average Shares
$ 1.43M
Dividend Per Share
$ ―
Total Operating Income As Reported
$ ―
Reported Normalized Basic E P S
$ ―
Reported Normalized Diluted E P S
$ ―
Rent Expense Supplemental
$ ―
Total Expenses
$ 24.97M
Net Income From Continuing And Discontinued Operation
$ -24.74M
Normalized Income
$ -18.19M
Interest Expense
$ ―
EBIT
$ -24.70M
EBITDA
$ -24.70M
Currency in USD
Actuate Therapeutics, Inc. Earnings and Revenue History